{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:15:16Z","timestamp":1707524116933},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,9,3]]},"DOI":"10.7759\/cureus.10217","type":"journal-article","created":{"date-parts":[[2020,9,3]],"date-time":"2020-09-03T11:00:00Z","timestamp":1599130800000},"source":"Crossref","is-referenced-by-count":3,"title":["The Association of Renin-Angiotensin-Aldosterone System Inhibitors With Outcomes Among a Predominantly Ethnic Minority Patient Population Hospitalized With COVID-19: The Bronx Experience"],"prefix":"10.7759","author":[{"given":"Muhammad","family":"Adrish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sridhar","family":"Chilimuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haozhe","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhitha","family":"Mantri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alla","family":"Yugay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maleeha","family":"Zahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2019.05.003","article-title":"Blood pressure and the new ACC\/AHA hypertension guidelines","volume":"30","author":"Flack JM","year":"2020","unstructured":"Flack JM, Adekola B. Blood pressure and the new ACC\/AHA hypertension guidelines. Trends Cardiovasc Med. 2020, 30:160-164. 10.1016\/j.tcm.2019.05.003","journal-title":"Trends Cardiovasc Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu F","year":"2020","unstructured":"Wu F, Zhao S, Yu B, et al.. A new coronavirus associated with human respiratory disease in China. Nature. 2020, 579:265-269. 10.1038\/s41586-020-2008-3","journal-title":"Nature"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2006923","article-title":"Renin-angiotensin-aldosterone system blockers and the risk of Covid-19","volume":"382","author":"Mancia G","year":"2020","unstructured":"Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin-angiotensin-aldosterone system blockers and the risk of Covid-19. N Engl J Med. 2020, 382:2431-2440. 10.1056\/NEJMoa2006923","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","volume":"126","author":"Zhang P","year":"2020","unstructured":"Zhang P, Zhu L, Cai J, et al.. Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Cir Res. 2020, 126:1671-1681. 10.1161\/CIRCRESAHA.120.317134","journal-title":"Cir Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.0757","article-title":"Coronavirus infections\u2014more than just the common cold","volume":"323","author":"Paules CI","year":"2020","unstructured":"Paules CI, Marston HD, Fauci AS. Coronavirus infections\u2014more than just the common cold. JAMA. 2020, 323:707-708. 10.1001\/jama.2020.0757","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.7197","article-title":"Variation in COVID-19 hospitalizations and deaths across New York City boroughs","volume":"323","author":"Wadhera RK","year":"2020","unstructured":"Wadhera RK, Wadhera P, Gaba P, Figueroa JF, Maddox KE, Yeh RW, Shen C. Variation in COVID-19 hospitalizations and deaths across New York City boroughs. JAMA. 2020, 323:2192-2195. 10.1001\/jama.2020.7197","journal-title":"JAMA"},{"key":"ref7","unstructured":"New York Daily News. South Bronx is poorest district in nation, U.S. Census Bureau finds: 38% live below poverty line. (2010). Accessed: September 1, 2020: https:\/\/www.nydailynews.com\/new-york\/south-bronx-poorest-district-nation-u-s-census-bureau-finds-38-live-poverty-line...."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202003-0736LE","article-title":"Clinical course and outcomes of 344 intensive care patients with COVID-19","volume":"201","author":"Wang Y","year":"2020","unstructured":"Wang Y, Lu X, Li Y, et al.. Clinical course and outcomes of 344 intensive care patients with COVID-19. Am J Respir Crit Care Med. 2020, 201:1430-1434. 10.1164\/rccm.202003-0736LE","journal-title":"Am J Respir Crit Care Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2010419","article-title":"Clinical characteristics of Covid-19 in New York City","volume":"382","author":"Goyal P","year":"2020","unstructured":"Goyal P, Choi JJ, Pinheiro LC, et al.. Clinical characteristics of Covid-19 in New York City. N Engl J Med. 2020, 382:2372-2374. 10.1056\/NEJMc2010419","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","volume":"323","author":"Richardson S","year":"2020","unstructured":"Richardson S, Hirsch JS, Narasimhan M, et al.. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020, 323:2052-2059. 10.1001\/jama.2020.6775","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann M","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, et al.. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020, 181:271-280. 10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target","volume":"46","author":"Zhang H","year":"2020","unstructured":"Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020, 46:586-590. 10.1007\/s00134-020-05985-9","journal-title":"Intensive Care Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba K","year":"2005","unstructured":"Kuba K, Imai Y, Rao S, et al.. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005, 11:875-879. 10.1038\/nm1267","journal-title":"Nat Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-10-0045","article-title":"Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis","volume":"74","author":"Imai Y","year":"2010","unstructured":"Imai Y, Kuba K, Ohto-Nakanishi T, Penninger JM. Angiotensin-converting enzyme 2 (ACE2) in disease pathogenesis. Circ J. 2010, 74:405-410. 10.1253\/circj.cj-10-0045","journal-title":"Circ J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-019-1003-2","article-title":"Pro-inflammatory cytokines and resistant hypertension: potential for novel treatments?","volume":"21","author":"Pioli MR","year":"2019","unstructured":"Pioli MR, de Faria AP. Pro-inflammatory cytokines and resistant hypertension: potential for novel treatments?. Curr Hypertens Rep. 2019, 21:95. 10.1007\/s11906-019-1003-2","journal-title":"Curr Hypertens Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1329","article-title":"The dilemma of coronavirus disease 2019, aging, and cardiovascular disease: insights from cardiovascular aging science (Epub ahead of print)","author":"AlGhatrif M","year":"2020","unstructured":"AlGhatrif M, Cingolani O, Lakatta EG. The dilemma of coronavirus disease 2019, aging, and cardiovascular disease: insights from cardiovascular aging science (Epub ahead of print). JAMA Cardiol. 2020, 10.1001\/jamacardio.2020.1329","journal-title":"JAMA Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2006.01.059","article-title":"Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease","volume":"98","author":"Ferrario CM","year":"2006","unstructured":"Ferrario CM, Strawn WB. Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol. 2006, 98:121-128. 10.1016\/j.amjcard.2006.01.059","journal-title":"Am J Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/39950-the-association-of-renin-angiotensin-aldosterone-system-inhibitors-with-outcomes-among-a-predominantly-ethnic-minority-patient-population-hospitalized-with-covid-19-the-bronx-experience","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:21:30Z","timestamp":1707506490000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/39950-the-association-of-renin-angiotensin-aldosterone-system-inhibitors-with-outcomes-among-a-predominantly-ethnic-minority-patient-population-hospitalized-with-covid-19-the-bronx-experience"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,3]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.10217","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,3]]}}}